作者: Emilio Fernández Espejo , Ramiro José González Aparicio
DOI:
关键词: Medicine 、 Pharmacology 、 Involuntary movement 、 Disease 、 Neurotrophic factors 、 Glial cell line-derived neurotrophic factor 、 Transforming growth factor
摘要: Pharmaceutical composition comprising the glial-derived neurotrophic factor (GDNF) and transforming beta 1 (TGF-β1) in a range of GDNF:TGF-β concentrations from 2:1 to 4:1. Moreover present invention relates use said pharmaceutical for preparation medicament treatment neurological disease. Preferably disease is neurodegenerative Said may with dyskinesias or other abnormal involuntary movements. Parkinson's